← ANALYST RATINGS · TIPRANKS
Haemonetics (HAE): analyst forecast and price target
Analyst consensus
Strong Buy7 Buy2 Hold0 Sell
Ratings of 9 analysts in the last 3 months12-month forecast
Based on 9 price targets given in the last 3 months, the average target is $125, the highest $140, the lowest $86.00. The average is +6.0% from the last price of $118.
Analyst ratings 14
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $111 → $131+18.0% | Buy | +10.8% | Upgrade | 09.10.26on TipRanks 11:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $108 → $129+19.4% | Hold | +9.1% | Reiterated | 09.10.26on TipRanks 11:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $109 → $130+19.3% | Hold | +9.9% | Reiterated | 09.10.26on TipRanks 11:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $107 → $127+18.7% | Hold | +7.4% | Reiterated | 09.10.26on TipRanks 11:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $113 → $134+18.6% | Buy | +13.3% | Reiterated | 09.10.26on TipRanks 11:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $113 → $134+18.6% | Buy | +13.3% | Reiterated | 09.10.26on TipRanks 11:05 | — | |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $95.00 → $140+47.4% | Buy | +18.4% | Reiterated | 09.10.26on TipRanks 10:00 | −1.3%next day +2.9% · 5 days +1.6% | ↗ |
| Michael Petusky★★★★★★★★★★#4246 · hits 45% · avg +2.3% | Barrington | $118 → $140+18.6% | Buy | +18.4% | Reiterated | 09.10.26on TipRanks 07:40 | −1.3%next day +2.9% · 5 days +1.6% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $120 → $140+16.7% | Buy | +18.4% | Reiterated | 08.10.26on TipRanks Oct 9 04:50 | +17.9%next day −1.3% · 5 days +1.8% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $116 → $111−4.3% | Hold | −6.2% | Downgrade | 08.10.26on TipRanks 12:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $114 → $108−5.3% | Hold | −8.7% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $116 → $109−6.0% | Hold | −7.8% | Downgrade | 08.10.26on TipRanks 12:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $112 → $107−4.5% | Hold | −9.5% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $117 → $113−3.4% | Buy | −4.5% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $117 → $113−3.4% | Buy | −4.5% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| Marie Thibault★★★★★★★★★★#12343 · hits 40% · avg −9.7% | BTIG | $110 → $130+18.2% | Buy | +9.9% | Reiterated | 08.10.26on TipRanks 09:25 | +17.9%next day −1.3% · 5 days +1.8% | ↗ |
| Michael Petusky★★★★★★★★★★#4246 · hits 45% · avg +2.3% | Barrington | $118 | Buy | −0.2% | Reiterated | 01.10.26on TipRanks 10:35 | −1.1%next day −0.4% · 5 days +13.2% | ↗ |
| Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% | Citi | $92.00 → $123+33.7% | Buy | +4.0% | Upgrade | 18.09.26on TipRanks Sep 17 05:25 | +0.1%next day +0.6% · 5 days −2.3% | ↗ |
| Andrew Cooper★★★★★★★★★★#11107 · hits 40% · avg −3.0% | Raymond James | $105 → $125+19.0% | Buy | +5.7% | Reiterated | 03.09.26on TipRanks 08:50 | −1.1%next day +0.5% · 5 days +1.0% | ↗ |
| David Rescott★★★★★★★★★★#3448 · hits 49% · avg +5.1% | Robert W. Baird | $96.00 → $119+24.0% | Buy | +0.6% | Reiterated | 21.08.26on TipRanks 07:25 | +0.1%next day −0.1% · 5 days −4.9% | ↗ |
| Michael Petusky★★★★★★★★★★#4246 · hits 45% · avg +2.3% | Barrington | $95.00 → $118+24.2% | Buy | −0.2% | Reiterated | 19.08.26on TipRanks 07:40 | +3.4%next day +0.7% · 5 days −1.3% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $99.00 → $116+17.2% | Buy | −1.9% | Reiterated | 19.08.26on TipRanks 04:07 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $99.00 → $114+15.2% | Hold | −3.6% | Reiterated | 19.08.26on TipRanks 04:07 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $99.00 → $116+17.2% | Buy | −1.9% | Reiterated | 19.08.26on TipRanks 04:07 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $97.00 → $112+15.5% | Hold | −5.3% | Reiterated | 19.08.26on TipRanks 04:07 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $102 → $117+14.7% | Buy | −1.1% | Reiterated | 19.08.26on TipRanks 04:07 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $102 → $117+14.7% | Buy | −1.1% | Reiterated | 19.08.26on TipRanks 04:07 | — | |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | — | Hold | — | Reiterated | 18.08.26on TipRanks 09:55 | +16.6%next day +3.4% · 5 days +3.7% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $1.00 → $120+11,900.0% | Buy | +1.5% | Assigned | 18.08.26on TipRanks 07:35 | +16.6%next day +3.4% · 5 days +3.7% | ↗ |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $90.00 → $95.00+5.6% | Buy | −19.7% | Reiterated | 11.08.26on TipRanks Aug 12 08:15 | +1.0%next day +4.5% · 5 days +20.4% | ↗ |
| Allen Gong★★★★★★★★★★#2251 · hits 46% · avg +14.7% | J.P. Morgan | $86.00 | Hold | −27.3% | Reiterated | 10.08.26on TipRanks Aug 11 08:07 | −1.4%next day +1.0% · 5 days +4.3% | ↗ |
| Marie Thibault★★★★★★★★★★#12343 · hits 40% · avg −9.7% | BTIG | $84.00 | Buy | −29.0% | Reiterated | 26.06.26on TipRanks 06:15 | +0.3%next day −4.5% · 5 days −6.0% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Haemonetics
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $112 at a price of $105 (+6.6%); now: $125 at $118 (+6.0%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 0 | 0 | 0 |
| Buy | 4 | 8 | 9 | 15 | 13 | 15 |
| Hold | 5 | 4 | 4 | 6 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q2 2027, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.29 (from $1.21 to $1.37). Last quarter: $1.14.
Sales
Next quarter’s sales estimate — $345M (from $338M to $355M). Last quarter: $339M.
Best top-analyst consensus in the sector · Healthcare
About Haemonetics
- CEO: Christopher A. Simon
- Employees: 3,009
- 125 Summer Street, Boston, MA, 02110, US
- www.haemonetics.com
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
Data from the stock’s TipRanks forecast page, read 63 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗